Beam Therapeutics BEAM Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by Beam Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The official record: Beam Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Beam Therapeutics's net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Beam Therapeutics's net income?
- Beam Therapeutics (BEAM) reported net income of -$94.32M in Q1 2026.
- How has Beam Therapeutics's net income changed year-over-year?
- Beam Therapeutics's net income increased by 12.9% year-over-year, from -$108.33M to -$94.32M.
- What is the long-term trend for Beam Therapeutics's net income?
- Over 2 years (2021 to 2024), Beam Therapeutics's net income has grown at a 0.8% compound annual growth rate (CAGR), from -$370.64M to -$376.74M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.